In This Article:
-
Total Revenue (Q4 2024): $12.4 million, down 18% compared to Q4 2023.
-
Operating Expenses (Q4 2024): $8.9 million, a decrease of 29% year-over-year.
-
Income from Operations (Q4 2024): $3.5 million, an increase of 40% compared to $2.5 million in the prior year.
-
Net Income (Q4 2024): $29.2 million or $3.64 per basic share and $3.41 per fully diluted share.
-
Cash, Cash Equivalents, and Restricted Cash (Dec 31, 2024): $8.9 million.
-
Bitcoin Holdings: 3,192 bitcoins valued at over $300 million, with an average cost basis of $87,854 per Bitcoin.
-
Convertible Senior Notes Offering: $100 million of notes issued with a 4.25% interest rate, maturing in August 2030.
-
Bitcoin Purchases (Q4 2024): 1,280 bitcoins for $121.3 million.
-
Additional Bitcoin Purchases (Post Q4 2024): 894 bitcoins for $90.7 million.
Release Date: February 18, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Semler Scientific Inc (NASDAQ:SMLR) achieved record cash generation of over $24 million in 2024 from healthcare operations.
-
The company adopted Bitcoin as its primary treasury reserve asset, becoming the second US public company to do so, and has seen a 152% positive yield since adoption.
-
Semler Scientific Inc (NASDAQ:SMLR) has accumulated 3,192 bitcoins, valued at over $300 million, making it the tenth largest corporate holder of Bitcoin.
-
The company's market capitalization has grown by more than 200% since adopting Bitcoin as a treasury strategy.
-
Semler Scientific Inc (NASDAQ:SMLR) is pursuing a new 510(k) clearance for an extension of its QuantaFlo technology, aiming to expand its product offerings in the cardiovascular space.
Negative Points
-
Total revenues in Q4 2024 were $12.4 million, down about 18% compared to the fourth quarter of 2023.
-
The company expects further pressure on revenues in 2025 due to the phasing of the 2024 CMS rate announcement.
-
Two largest customers, including their affiliates, comprised 70% of quarterly revenues, indicating high customer concentration risk.
-
The adoption of a new accounting standard for Bitcoin assets may introduce volatility into reported net income.
-
Semler Scientific Inc (NASDAQ:SMLR) faces challenges in maintaining QuantaFlo revenue due to government decisions affecting payment for risk adjustment for PAD.
Q & A Highlights
Q: Why did Semler Scientific decide to do the convertible note offering? A: Eric Semler, Independent Chairman of the Board, explained that the company chose the convertible note offering as it is a cheaper source of funding and less dilutive to stockholders. The offering allowed them to raise a large amount of capital quickly, initially targeting $75 million but increasing to $100 million due to high demand. The cap call created a conversion premium 75% higher than the stock's trading price at the time of the announcement.